Synergy Spine Solutions develops the Synergy Disc, an artificial cervical disc replacement designed to restore motion and alignment to the cervical spine. The company is advancing clinical evidence, having completed enrollment for its 1-level IDE trial in June 2023 and currently conducting a U.S. IDE 2-level clinical trial. The 2-level study is a multi-center, prospective, non-randomized, historically controlled trial that will enroll 200 patients at up to 25 sites and compare the Synergy Disc to anterior cervical discectomy and fusion (ACDF) for symptomatic two-level disease from C3 to C7. Synergy plans to use its clinical data to support regulatory submissions and market access. The company is pursuing Pre-Market Approval applications to the FDA and intends to continue commercialization efforts outside the United States.

Total raised

$30M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2024